Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3102 ARTÍCULOS , VIENDO DEL 1171 AL 1185

Involvement of the peripheral nervous system in synucleinopathies, tauopathies and other neurodegenerative proteinopathies of the brain

Wakabayashi K, Mori F, Tanji K, Orimo S, Takahashi H.

Acta Neuropathol. 2010 Jul;120(1):1-12. doi: 10.1007/s00401-010-0706-x. Epub 2010 Jun 9.

Increasing access to specialty care: a pilot, randomized controlled trial of telemedicine for Parkinson's disease

Dorsey ER, Deuel LM, Voss TS, Finnigan K, George BP, Eason S, Miller D, Reminick JI, Appler A, Polanowicz J, Viti L, Smith S, Joseph A, Biglan KM.

Mov Disord. 2010 Aug 15;25(11):1652-9. doi: 10.1002/mds.23145.

Subthalamic span of beta oscillations predicts deep brain stimulation efficacy for patients with Parkinson's disease

Zaidel A, Spivak A, Grieb B, Bergman H, Israel Z.

Brain. 2010 Jul;133(Pt 7):2007-21. doi: 10.1093/brain/awq144. Epub 2010 Jun 9.

SNARE protein redistribution and synaptic failure in a transgenic mouse model of Parkinson's disease

Garcia-Reitböck P, Anichtchik O, Bellucci A, Iovino M, Ballini C, Fineberg E, Ghetti B, Della Corte L, Spano P, Tofaris GK, Goedert M, Spillantini MG.

Brain. 2010 Jul;133(Pt 7):2032-44. doi: 10.1093/brain/awq132. Epub 2010 Jun 9.

Compulsive singing associated with a dopamine agonist in Parkinson disease

Kataoka H, Ueno S.

Cogn Behav Neurol. 2010 Jun;23(2):140-1. doi: 10.1097/WNN.0b013e3181c12af2.

Transdermal rotigotine for the perioperative management of Parkinson's disease

Wüllner U, Kassubek J, Odin P, Schwarz M, Naumann M, Häck HJ, Boroojerdi B, Reichmann H; NEUPOS Study Group.

J Neural Transm (Vienna). 2010 Jul;117(7):855-9. doi: 10.1007/s00702-010-0425-4. Epub 2010 Jun 10.

The identification of Parkinson's disease subtypes using cluster analysis: a systematic review

van Rooden SM, Heiser WJ, Kok JN, Verbaan D, van Hilten JJ, Marinus J.

Mov Disord. 2010 Jun 15;25(8):969-78. doi: 10.1002/mds.23116.

Parkinson's disease psychosis 2010: a review article

Friedman JH.

Parkinsonism Relat Disord. 2010 Nov;16(9):553-60. doi: 10.1016/j.parkreldis.2010.05.004. Epub 2010 Jun 9.

Modeling a sensitization stage and a precipitation stage for Parkinson's disease using prenatal and postnatal 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration

Muthian G, Mackey V, King J, Charlton CG.

Neuroscience. 2010 Sep 1;169(3):1085-93. doi: 10.1016/j.neuroscience.2010.04.080. Epub 2010 Jun 9.

Selective cell death in neurodegeneration: why are some neurons spared in vulnerable regions?

Double KL, Reyes S, Werry EL, Halliday GM.

Prog Neurobiol. 2010 Nov;92(3):316-29. doi: 10.1016/j.pneurobio.2010.06.001. Epub 2010 Jun 10.

Lower prevalence of sleep disturbances in familial versus sporadic Parkinson's disease: a questionnaire based study

Vibha D, Shukla G, Singh S, Goyal V, Srivastava AK, Behari M.

J Neurol Sci. 2010 Aug 15;295(1-2):27-30. doi: 10.1016/j.jns.2010.05.024. Epub 2010 Jun 11.

Molecular mechanisms of pesticide-induced neurotoxicity: Relevance to Parkinson's disease

Franco R, Li S, Rodriguez-Rocha H, Burns M, Panayiotidis MI.

Chem Biol Interact. 2010 Nov 5;188(2):289-300. doi: 10.1016/j.cbi.2010.06.003. Epub 2010 Jun 11.

An Examination of Psychotropic Medication Side Effects: does taking a greater number of psychotropic medications from different classes affect presentation of side effects in adults with ID?

Mahan S, Holloway J, Bamburg JW, Hess JA, Fodstad JC, Matson JL.

Res Dev Disabil. 2010 Nov-Dec;31(6):1561-9. doi: 10.1016/j.ridd.2010.05.006. Epub 2010 Jun 9.

Effectiveness of an online fatigue self-management programme for people with chronic neurological conditions: a randomized controlled trial

Ghahari S, Leigh Packer T, Passmore AE.

Clin Rehabil. 2010 Aug;24(8):727-44. doi: 10.1177/0269215509360648. Epub 2010 Jun 11.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias